IC
ZLAB icon

Ikarian Capital’s Zai Lab ZLAB Stock Holding History

Ikarian Capital’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-81,843
Closed -$278K – 163
2022
Q2 		$278K Hold
81,843
– – 0.05% 110
2022
Q1 		$376K Buy
+81,843
New +$3.96M 0.05% 147
2021
Q2 		– Sell
-17,000
Closed -$2.73M – 297
2021
Q1 		$2.25M Buy
+17,000
New +$2.63M 0.08% 193

Other funds holding ZLAB

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ikarian Capital's ZLAB Position: Q3 2022 in Review

Ikarian Capital sold out of Zai Lab (ZLAB) in Q3 2022, closing a stake of 81,843 shares — an estimated $278K sold.

Ikarian Capital first reported a position in ZLAB in Q1 2021 and held it in 3 quarters. The position peaked at $2.25M in Q1 2021. 170 funds tracked by Wall St. Rank hold ZLAB as of Q3 2022.

  • Ikarian Capital reported no remaining Zai Lab position as of Q3 2022 after selling out during the quarter.
  • Ikarian Capital sold 81,843 Zai Lab shares in Q3 2022, an estimated $278K.
  • Ikarian Capital first reported a position in Zai Lab in Q1 2021 and held it in 3 quarters.
  • Ikarian Capital's Zai Lab position peaked at $2.25M in Q1 2021.
  • 170 funds tracked by Wall St. Rank held Zai Lab as of Q3 2022.

Based on Ikarian Capital's 13F filing for Q3 2022, filed 14 Nov 2022.